Vaxcyte, Inc. - Common Stock (PCVX)

CUSIP: 92243G108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
131,352,709
Total 13F shares
42,260,768
Share change
+2,237,772
Total reported value
$1,118,933,017
Price per share
$26.57
Number of holders
83
Value change
+$58,331,379
Number of buys
53
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.9%
6,375,763
$314,836,000 30 Sep 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
4%
5,283,818
$260,915,000 30 Sep 2020
13F
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
3.9%
5,156,553
$254,631,000 30 Sep 2020
13F
Abingworth LLP
13F
Company
3.2%
4,168,718
$205,851,000 30 Sep 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
3.2%
4,196,429
$199,839,000 30 Sep 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
1.8%
2,309,554
$114,046,000 30 Sep 2020
13F
Medicxi Ventures Management (Jersey) Ltd
13F
Company
1.4%
1,887,478
$93,203,000 30 Sep 2020
13F
VANGUARD GROUP INC
13F
Company
1%
1,352,820
$66,802,000 30 Sep 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.84%
1,097,856
$54,212,000 30 Sep 2020
13F
BlackRock Finance, Inc.
13F
Company
0.76%
1,004,528
$49,603,000 30 Sep 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.65%
850,000
$41,973,000 30 Sep 2020
13F
Novo Holdings A/S
13F
Company
0.5%
651,255
$32,159,000 30 Sep 2020
13F
ORBIMED ADVISORS LLC
13F
Company
0.49%
640,760
$31,641,000 30 Sep 2020
13F
Foresite Capital Management IV, LLC
13F
Company
0.35%
465,821
$23,002,000 30 Sep 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.3%
400,070
$19,755,000 30 Sep 2020
13F
Opaleye Management Inc.
13F
Company
0.24%
313,000
$15,456,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
292,413
$14,439,000 30 Sep 2020
13F
STATE STREET CORP
13F
Company
0.21%
274,041
$13,532,000 30 Sep 2020
13F
NORTHERN TRUST CORP
13F
Company
0.16%
214,527
$10,593,000 30 Sep 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.09%
116,065
$5,732,000 30 Sep 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
95,660
$4,724,000 30 Sep 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.06%
77,659
$3,835,000 30 Sep 2020
13F
Bank of New York Mellon Corp
13F
Company
0.04%
53,015
$2,618,000 30 Sep 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.04%
52,559
$2,595,000 30 Sep 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
41,086
$2,029,000 30 Sep 2020
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.02%
28,778
$1,482,000 30 Sep 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.02%
28,800
$1,422,000 30 Sep 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
27,559
$1,361,000 30 Sep 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
26,400
$1,304,000 30 Sep 2020
13F
MARSHALL WACE, LLP
13F
Company
0.02%
23,453
$1,158,000 30 Sep 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
20,401
$1,007,000 30 Sep 2020
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.02%
20,000
$988,000 30 Sep 2020
13F
NORGES BANK
13F
Company
0.02%
20,000
$988,000 30 Sep 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.01%
18,894
$933,000 30 Sep 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
16,500
$815,000 30 Sep 2020
13F
Ikarian Capital, LLC
13F
Company
0.01%
16,110
$796,000 30 Sep 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
13,797
$681,000 30 Sep 2020
13F
Athanor Capital, LP
13F
Company
0.01%
13,516
$667,000 30 Sep 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
10,889
$538,000 30 Sep 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
9,963
$492,000 30 Sep 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
9,737
$481,000 30 Sep 2020
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.01%
9,659
$477,000 30 Sep 2020
13F
MIRABELLA FINANCIAL SERVICES LLP
13F
Company
0.01%
9,432
$466,000 30 Sep 2020
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
8,028
$396,000 30 Sep 2020
13F
MetLife Investment Management, LLC
13F
Company
0.01%
7,862
$388,226 30 Sep 2020
13F
QS Investors, LLC
13F
Company
0.01%
7,265
$359,000 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
6,788
$350,000 30 Sep 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0%
5,853
$289,000 30 Sep 2020
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0%
5,397
$266,504 30 Sep 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0%
5,102
$252,000 30 Sep 2020
13F

Institutional Holders of Vaxcyte, Inc. - Common Stock (PCVX) as of Q4 2020

As of 31 Dec 2020, Vaxcyte, Inc. - Common Stock (PCVX) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,260,768 shares. The largest 10 holders included FMR LLC, TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, Abingworth LLP, RA CAPITAL MANAGEMENT, L.P., FRAZIER MANAGEMENT LLC, Pivotal bioVenture Partners Investment Advisor LLC, Medicxi Ventures Management (Jersey) Ltd, BlackRock Inc., and VANGUARD GROUP INC. This page lists 83 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
60
Q4 2020 holders
83
Holder diff
23
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .